Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia
- 13 April 2010
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 84 (5), 406-411
- https://doi.org/10.1111/j.1600-0609.2010.01412.x
Abstract
Chronic lymphocytic leukemia (CLL) is characterized by a highly variable clinical course. This retrospective study is planned to assess the prognostic value of serum free light chain (sFLC) levels and FLC ratio (FLCR) in CLL. Quantitative levels of sFLC were measured nephelometrically in sera collected at diagnosis. The expressions of ZAP70 and CD38 were quantified by flow cytometry. Chromosomal abnormalities were determined by interphase fluorescence in situ hybridization (FISH). In a cohort of 101 patients with a median follow-up of 29 (1-234) months, sFLC levels were found to be high in 55 patients (54.5%). An abnormal FLCR was found in 30 patients (29.7%). FISH-based genetic risk groups did not differ significantly with respect to sFLC and FLCR (P > 0.05). Median time to first treatment was shorter in patients with high sFLC levels (P = 0.02). Median overall survival (OS) was shorter in patients with high sFLC levels (P = 0.01) and abnormal FLCR (P = 0.05). In patients with early stage disease, median OS was shorter in high sFLC (P = 0.03) and abnormal FLCR groups (P = 0.048). A relationship was observed between abnormal sFLC levels and CD38 positivity on logistic regression analysis (P = 0.003; OR: 4.44; 95% CI: 1.66-11.8). This study highlighted the adverse prognostic impact of high sFLC levels and abnormal FLCR with regard to survival in CLL, even in early stage patients. Prospective studies are warranted to validate the adverse impact of sFLC and FLCR on clinical outcome.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 2009
- Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaBritish Journal of Haematology, 2008
- New prognostic markers in chronic lymphocytic leukemiaBlood Reviews, 2008
- Chronic lymphocytic leukaemiaThe Lancet, 2008
- Molecular diagnostics in chronic lymphocytic leukemia – Pathogenetic and clinical implicationsLeukemia & Lymphoma, 2008
- The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemiaLeukemia, 2007
- Serum-free light chain—a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaTranslational Research, 2007
- Risk Stratification in Chronic Lymphocytic LeukemiaSeminars in Oncology, 2006
- Guidelines on the diagnosis and management of chronic lymphocytic leukaemiaBritish Journal of Haematology, 2004
- Monoclonal Bence Jones proteinuria in chronic lymphocytic leukaemiaScandinavian Journal of Haematology, 1986